Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05523726 · ClinicalTrials.gov registry record · NA

Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)

A NA study of Insomnia, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
167
Enrollment target
1
Study location

NCT05523726 is a NA study of Insomnia that has completed, run by Henry Ford Health System. The registered enrollment target is 167 participants, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05523726, a NA study of Insomnia, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
167 participants
Enrollment target
1
Study location

Study Summary

This study is intended to assess the efficacy of preventative Cognitive Behavioral Therapy for Insomnia (pCBT-I) on reducing the severity and stopping the progression of acute insomnia and depression. We also hope to gain a deeper understanding of the sociocultural, interpersonal, and individual factors that may have a role in development of insomnia and/or engagement with treatment plans.

Conditions Studied

Interventions

  • BEHAVIORAL pCBT-I

Study Locations (1)

Michigan

  • Henry Ford Columbus Medical Center - Novi

Trial Details

FieldValue
Enrollment Target 167 participants
Start Date 2022-12-01
Est. Completion 2026-03-13
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT05523726

The ClinicalTrials.gov registry entry for NCT05523726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 169-participant average among 151 other Insomnia trials with a reported enrollment target. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which pCBT-I is the first listed.

NCT05523726 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05523726 about?

NCT05523726 is a clinical study titled "Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)". This study is intended to assess the efficacy of preventative Cognitive Behavioral Therapy for Insomnia (pCBT-I) on reducing the severity and stopping the progression of acute insomnia and depression. We also hope to gain a deeper understanding of the sociocultural, interpersonal, and individual fac...

What is the current status of trial NCT05523726?

This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2022-12-01. Estimated completion is 2026-03-13.

What conditions does trial NCT05523726 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT05523726?

The interventions under investigation include: pCBT-I (BEHAVIORAL).

Who is sponsoring clinical trial NCT05523726?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05523726 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.